Klaria Pharma Holding AB (publ.) (STO: KLAR) Stock Analysis & Fundamentals

KLARKlaria Pharma Holding AB (publ.)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · klaria.com

1.076SEK+3.26%Mkt Cap: 24.52M $P/E: —Today

Klaria Pharma Holding AB (publ.), a pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock. Its product pipeline includes Sumatripta…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap24.52M $

Enterprise Value25.42M $

Revenue (TTM)9.57K $

Gross Profit9.57K $

Net Income (TTM)-4.50M $

Revenue/Share0.0000 USD

Last Price1.076 SEK

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees4

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINSE0007280326

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-10.96

EV/Revenue2657.49

P/S2636.86

P/B-12.76

EPS (TTM)-0.28

EPS (Forward)0.00

52W Range

0.435072% of range1.330

52W High1.330 SEK

52W Low0.4350 SEK

Profitability

Gross Margin100.00%

Oper. Margin-7208.00%

EBITDA Margin0.00%

Profit Margin-523.75%

ROE390.69%

ROA-144.65%

Growth

Revenue Growth-98.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-3.27M $

CapEx (TTM)—

FCF Margin-29827.12%

FCF Yield-11.64%

Net Debt902.96K $

Net Debt/EBITDA-0.39

Balance Sheet

Debt/Equity-2.08

Current Ratio0.06

Quick Ratio0.06

Book Value/Sh-0.0840 SEK

Cash/Share0.0010 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.245.98M

Float211.46M

Insiders14.03%

Institutions10.75%

Technical

SMA 500.8269 (+30.1%)

SMA 2000.8170 (+31.7%)

Beta1.19

S&P 52W Chg18.16%

Avg Vol (30d)650.20K

Avg Vol (10d)832.55K

Technical Indicators

RSI (14)75.3

MACD0.0525

MACD Signal0.0376

MACD Hist.+0.0149

BB Upper1.048 SEK

BB Middle0.8824 SEK

BB Lower0.7172 SEK

BB Width37.46%

ATR (14)0.0585 SEK

Vol Ratio (20d)1.64x